Detected ·
OMass Therapeutics
$310MSeries C
OMass Therapeutics announced a $310M Series C financing, co-led by Bain Capital, Forbion and Novo Holdings, to advance CAH and lupus treatments.
- Website
- www.omass.com
- linkedin.com/company/12654474
- Amount
- $310 000 000 USD
- Stage
- Series C
- Event
- Funding round
- Detected
- 2026-10-15 21:32:59 UTC
- Signal ID
- 9f9724cf-f2b2-41aa-9b6b-ebc1885bc829
As the API returns it
{
"id": "9f9724cf-f2b2-41aa-9b6b-ebc1885bc829",
"created_at": "2026-10-15T21:32:59.351750Z",
"company_name": "OMass Therapeutics",
"company_website_url": "www.omass.com",
"company_linkedin_url": "https://www.linkedin.com/company/12654474",
"event_type": "funding",
"funding_amount": 310000000,
"funding_currency": "USD",
"funding_stage": "series_c",
"message": "*OMass Therapeutics announced a $310M Series C financing, co-led by Bain Capital, Forbion and Novo Holdings, to advance CAH and lupus treatments.*"
}